{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:55:47Z","timestamp":1790909747996,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T00:00:00Z","timestamp":1248566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/nchembio.192","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T14:10:58Z","timestamp":1248617458000},"page":"640-646","source":"Crossref","is-referenced-by-count":75,"title":["Inhibition of a viral enzyme by a small-molecule dimer disruptor"],"prefix":"10.1038","volume":"5","author":[{"given":"Tina","family":"Shahian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lazic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leggy A","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Velusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Kiplin","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S","family":"Craik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,26]]},"reference":[{"key":"BFnchembio192_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1073\/pnas.93.1.13","volume":"93","author":"S Jones","year":"1996","unstructured":"Jones, S. & Thornton, J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA 93, 13\u201320 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio192_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A.L. & Groom, C.R. The druggable genome. Nat. Rev. Drug Discov. 1, 727\u2013730 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnchembio192_CR3","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1006\/jmbi.1998.2439","volume":"285","author":"L Lo Conte","year":"1999","unstructured":"Lo Conte, L., Chothia, C. & Janin, J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285, 2177\u20132198 (1999).","journal-title":"J. Mol. Biol."},{"key":"BFnchembio192_CR4","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/anie.200200558","volume":"42","author":"T Berg","year":"2003","unstructured":"Berg, T. Modulation of protein-protein interactions with small organic molecules. Angew. Chem. Int. Edn. Engl. 42, 2462\u20132481 (2003).","journal-title":"Angew. Chem. Int. Edn. Engl."},{"key":"BFnchembio192_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nature06526","volume":"450","author":"JA Wells","year":"2007","unstructured":"Wells, J.A. & McClendon, C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001\u20131009 (2007).","journal-title":"Nature"},{"key":"BFnchembio192_CR6","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","volume":"68","author":"C Tse","year":"2008","unstructured":"Tse, C. et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 68, 3421\u20133428 (2008).","journal-title":"Cancer Res."},{"key":"BFnchembio192_CR7","unstructured":"Fields, B.N. et al. Fields Virology 3177 (Lippincott Williams & Wilkins, Philadelphia, 2006)."},{"key":"BFnchembio192_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/jm030540h","volume":"47","author":"A Gopalsamy","year":"2004","unstructured":"Gopalsamy, A. et al. Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors. J. Med. Chem. 47, 1893\u20131899 (2004).","journal-title":"J. Med. Chem."},{"key":"BFnchembio192_CR9","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/JVI.68.6.3702-3712.1994","volume":"68","author":"M Gao","year":"1994","unstructured":"Gao, M. et al. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth. J. Virol. 68, 3702\u20133712 (1994).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/JVI.45.3.1056-1064.1983","volume":"45","author":"VG Preston","year":"1983","unstructured":"Preston, V.G., Coates, J.A. & Rixon, F.J. Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA. J. Virol. 45, 1056\u20131064 (1983).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR11","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1128\/JVI.74.15.6838-6848.2000","volume":"74","author":"AK Sheaffer","year":"2000","unstructured":"Sheaffer, A.K. et al. Evidence for controlled incorporation of herpes simplex virus type 1 UL26 protease into capsids. J. Virol. 74, 6838\u20136848 (2000).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR12","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1128\/JVI.67.10.5813-5822.1993","volume":"67","author":"SP Weinheimer","year":"1993","unstructured":"Weinheimer, S.P. et al. Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles. J. Virol. 67, 5813\u20135822 (1993).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR13","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1073\/pnas.88.23.10792","volume":"88","author":"AR Welch","year":"1991","unstructured":"Welch, A.R., Woods, A.S., McNally, L.M., Cotter, R.J. & Gibson, W. A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site. Proc. Natl. Acad. Sci. USA 88, 10792\u201310796 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio192_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/jm0102203","volume":"45","author":"AD Borthwick","year":"2002","unstructured":"Borthwick, A.D. et al. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality. J. Med. Chem. 45, 1\u201318 (2002).","journal-title":"J. Med. Chem."},{"key":"BFnchembio192_CR15","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0960-894X(02)00294-9","volume":"12","author":"AD Borthwick","year":"2002","unstructured":"Borthwick, A.D. et al. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability. Bioorg. Med. Chem. Lett. 12, 1719\u20131722 (2002).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnchembio192_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0960-894X(98)00032-8","volume":"8","author":"AD Borthwick","year":"1998","unstructured":"Borthwick, A.D. et al. Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease. Bioorg. Med. Chem. Lett. 8, 365\u2013370 (1998).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnchembio192_CR17","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1021\/jm970104t","volume":"40","author":"W Ogilvie","year":"1997","unstructured":"Ogilvie, W. et al. Peptidomimetic inhibitors of the human cytomegalovirus protease. J. Med. Chem. 40, 4113\u20134135 (1997).","journal-title":"J. Med. Chem."},{"key":"BFnchembio192_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/095632020001100101","volume":"11","author":"L Waxman","year":"2000","unstructured":"Waxman, L. & Darke, P.L. The herpesvirus proteases as targets for antiviral chemotherapy. Antivir. Chem. Chemother. 11, 1\u201322 (2000).","journal-title":"Antivir. Chem. Chemother."},{"key":"BFnchembio192_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nsb0901-810","volume":"8","author":"R Batra","year":"2001","unstructured":"Batra, R., Khayat, R. & Tong, L. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease. Nat. Struct. Biol. 8, 810\u2013817 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"BFnchembio192_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/jmbi.2001.4854","volume":"311","author":"M Buisson","year":"2001","unstructured":"Buisson, M. et al. Functional determinants of the Epstein-Barr virus protease. J. Mol. Biol. 311, 217\u2013228 (2001).","journal-title":"J. Mol. Biol."},{"key":"BFnchembio192_CR21","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1074\/jbc.271.13.7445","volume":"271","author":"PL Darke","year":"1996","unstructured":"Darke, P.L. et al. Active human cytomegalovirus protease is a dimer. J. Biol. Chem. 271, 7445\u20137449 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio192_CR22","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1021\/bi952842u","volume":"35","author":"SA Margosiak","year":"1996","unstructured":"Margosiak, S.A., Vanderpool, D.L., Sisson, W., Pinko, C. & Kan, C.C. Dimerization of the human cytomegalovirus protease: kinetic and biochemical characterization of the catalytic homodimer. Biochemistry 35, 5300\u20135307 (1996).","journal-title":"Biochemistry"},{"key":"BFnchembio192_CR23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nsmb1006","volume":"12","author":"AM Nomura","year":"2005","unstructured":"Nomura, A.M., Marnett, A.B., Shimba, N., Dotsch, V. & Craik, C.S. Induced structure of a helical switch as a mechanism to regulate enzymatic activity. Nat. Struct. Mol. Biol. 12, 1019\u20131020 (2005).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnchembio192_CR24","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1021\/bi011753g","volume":"41","author":"TR Pray","year":"2002","unstructured":"Pray, T.R., Reiling, K.K., Demirjian, B.G. & Craik, C.S. Conformational change coupling the dimerization and activation of KSHV protease. Biochemistry 41, 1474\u20131482 (2002).","journal-title":"Biochemistry"},{"key":"BFnchembio192_CR25","doi-asserted-by":"publisher","first-page":"12796","DOI":"10.1021\/bi001019h","volume":"39","author":"KK Reiling","year":"2000","unstructured":"Reiling, K.K., Pray, T.R., Craik, C.S. & Stroud, R.M. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements. Biochemistry 39, 12796\u201312803 (2000).","journal-title":"Biochemistry"},{"key":"BFnchembio192_CR26","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1074\/jbc.272.12.7732","volume":"272","author":"U Schmidt","year":"1997","unstructured":"Schmidt, U. & Darke, P.L. Dimerization and activation of the herpes simplex virus type 1 protease. J. Biol. Chem. 272, 7732\u20137735 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio192_CR27","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1021\/bi0523658","volume":"45","author":"AM Nomura","year":"2006","unstructured":"Nomura, A.M., Marnett, A.B., Shimba, N., Dotsch, V. & Craik, C.S. One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease. Biochemistry 45, 3572\u20133579 (2006).","journal-title":"Biochemistry"},{"key":"BFnchembio192_CR28","doi-asserted-by":"publisher","first-page":"6870","DOI":"10.1073\/pnas.0401613101","volume":"101","author":"AB Marnett","year":"2004","unstructured":"Marnett, A.B., Nomura, A.M., Shimba, N., Ortiz de Montellano, P.R. & Craik, C.S. Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor. Proc. Natl. Acad. Sci. USA 101, 6870\u20136875 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio192_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-2836(02)01040-9","volume":"324","author":"M Buisson","year":"2002","unstructured":"Buisson, M. et al. The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus. J. Mol. Biol. 324, 89\u2013103 (2002).","journal-title":"J. Mol. Biol."},{"key":"BFnchembio192_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/383275a0","volume":"383","author":"X Qiu","year":"1996","unstructured":"Qiu, X. et al. Unique fold and active site in cytomegalovirus protease. Nature 383, 275\u2013279 (1996).","journal-title":"Nature"},{"key":"BFnchembio192_CR31","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1073\/pnas.94.7.2874","volume":"94","author":"X Qiu","year":"1997","unstructured":"Qiu, X. et al. Crystal structure of varicella-zoster virus protease. Proc. Natl. Acad. Sci. USA 94, 2874\u20132879 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio192_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/383279a0","volume":"383","author":"HS Shieh","year":"1996","unstructured":"Shieh, H.S. et al. Three-dimensional structure of human cytomegalovirus protease. Nature 383, 279\u2013282 (1996).","journal-title":"Nature"},{"key":"BFnchembio192_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/383272a0","volume":"383","author":"L Tong","year":"1996","unstructured":"Tong, L. et al. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease. Nature 383, 272\u2013275 (1996).","journal-title":"Nature"},{"key":"BFnchembio192_CR34","doi-asserted-by":"publisher","first-page":"14023","DOI":"10.1021\/bi9712697","volume":"36","author":"SS Hoog","year":"1997","unstructured":"Hoog, S.S. et al. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease\/inhibitor complex. Biochemistry 36, 14023\u201314029 (1997).","journal-title":"Biochemistry"},{"key":"BFnchembio192_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/jmbi.1999.2791","volume":"289","author":"TR Pray","year":"1999","unstructured":"Pray, T.R., Nomura, A.M., Pennington, M.W. & Craik, C.S. Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease. J. Mol. Biol. 289, 197\u2013203 (1999).","journal-title":"J. Mol. Biol."},{"key":"BFnchembio192_CR36","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1128\/JVI.78.12.6657-6665.2004","volume":"78","author":"N Shimba","year":"2004","unstructured":"Shimba, N., Nomura, A.M., Marnett, A.B. & Craik, C.S. Herpesvirus protease inhibition by dimer disruption. J. Virol. 78, 6657\u20136665 (2004).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/cc050142v","volume":"8","author":"F Lu","year":"2006","unstructured":"Lu, F. et al. Proteomimetic libraries: design, synthesis, and evaluation of p53\u2013MDM2 interaction inhibitors. J. Comb. Chem. 8, 315\u2013325 (2006).","journal-title":"J. Comb. Chem."},{"key":"BFnchembio192_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/72642","volume":"18","author":"BJ Backes","year":"2000","unstructured":"Backes, B.J., Harris, J.L., Leonetti, F., Craik, C.S. & Ellman, J.A. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat. Biotechnol. 18, 187\u2013193 (2000).","journal-title":"Nat. Biotechnol."},{"key":"BFnchembio192_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jmb.2007.07.073","volume":"373","author":"A Lazic","year":"2007","unstructured":"Lazic, A., Goetz, D.H., Nomura, A.M., Marnett, A.B. & Craik, C.S. Substrate modulation of enzyme activity in the herpesvirus protease family. J. Mol. Biol. 373, 913\u2013923 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFnchembio192_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nprot.2006.77","volume":"1","author":"BY Feng","year":"2006","unstructured":"Feng, B.Y. & Shoichet, B.K. A detergent-based assay for the detection of promiscuous inhibitors. Nat. Protoc. 1, 550\u2013553 (2006).","journal-title":"Nat. Protoc."},{"key":"BFnchembio192_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1126\/science.1169378","volume":"324","author":"GM Lee","year":"2009","unstructured":"Lee, G.M. & Craik, C.S. Trapping moving targets with small molecules. Science 324, 213\u2013215 (2009).","journal-title":"Science"},{"key":"BFnchembio192_CR42","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.274.5289.948","volume":"274","author":"PH Kussie","year":"1996","unstructured":"Kussie, P.H. et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948\u2013953 (1996).","journal-title":"Science"},{"key":"BFnchembio192_CR43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0092-8674(00)80157-9","volume":"86","author":"P Chen","year":"1996","unstructured":"Chen, P. et al. Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad. Cell 86, 835\u2013843 (1996).","journal-title":"Cell"},{"key":"BFnchembio192_CR44","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1128\/JVI.77.8.4836-4847.2003","volume":"77","author":"TD Wu","year":"2003","unstructured":"Wu, T.D. et al. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol. 77, 4836\u20134847 (2003).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR45","doi-asserted-by":"publisher","first-page":"12461","DOI":"10.1073\/pnas.0404781101","volume":"101","author":"JA Hardy","year":"2004","unstructured":"Hardy, J.A., Lam, J., Nguyen, J.T., O'Brien, T. & Wells, J.A. Discovery of an allosteric site in the caspases. Proc. Natl. Acad. Sci. USA 101, 12461\u201312466 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio192_CR46","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1073\/pnas.0602571103","volume":"103","author":"JM Scheer","year":"2006","unstructured":"Scheer, J.M., Romanowski, M.J. & Wells, J.A. A common allosteric site and mechanism in caspases. Proc. Natl. Acad. Sci. USA 103, 7595\u20137600 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio192_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1042\/BST0350551","volume":"35","author":"L Bannwarth","year":"2007","unstructured":"Bannwarth, L. & Reboud-Ravaux, M. An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface. Biochem. Soc. Trans. 35, 551\u2013554 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnchembio192_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chembiol.2006.02.012","volume":"13","author":"SG Lee","year":"2006","unstructured":"Lee, S.G. & Chmielewski, J. Rapid synthesis and in situ screening of potent HIV-1 protease dimerization inhibitors. Chem. Biol. 13, 421\u2013426 (2006).","journal-title":"Chem. Biol."},{"key":"BFnchembio192_CR49","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/JVI.71.9.7030-7038.1997","volume":"71","author":"A Unal","year":"1997","unstructured":"Unal, A. et al. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 71, 7030\u20137038 (1997).","journal-title":"J. Virol."},{"key":"BFnchembio192_CR50","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1128\/JVI.02821-06","volume":"81","author":"EJ Brignole","year":"2007","unstructured":"Brignole, E.J. & Gibson, W. Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain. J. Virol. 81, 4091\u20134103 (2007).","journal-title":"J. Virol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.192","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:39:52Z","timestamp":1684424392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,26]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["BFnchembio192"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.192","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,26]]}}}